FARALLON CAPITAL MANAGEMENT, L.L.C. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0000909661

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Tom Steyer — tracked via quarterly SEC 13F filings · All famous investors

LargeHigh Turnover how tags are computed

Q4 2023 · 156 positions · Total reported value $21.75B · Top-10 concentration 52.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 64.4% · 43 new · 19 cut · 23 exited

Active Share (vs S&P 500): 91.2% · vs QQQ: 92.5% — share of the book that differs from index weights (higher = more active) · ranking

In its Q4 2023 13F filing, FARALLON CAPITAL MANAGEMENT, L.L.C. disclosed 156 equity positions with a combined reported value of $21.75B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 52.0% of reported value. HoldingsHub classifies the profile as Large / High Turnover.

The largest disclosed positions as of Q4 2023 were SPY ($5.87B), PXD ($701.63M), IQV ($685.12M). By sector, the heaviest allocations are Health Care 21.1%, Technology 12.4%. Versus the prior quarter, allocation shifted toward Industrials (+1.3pp), Consumer Discretionary (+1.1pp) and away from Technology (-0.5pp), Communication Services (-0.9pp).

Versus the prior quarter, FARALLON CAPITAL MANAGEMENT, L.L.C. opened 43 new positions, trimmed 19 and fully exited 23, a turnover rate of 64.4% of positions. The portfolio's overlap with the prior quarter was 68% of names.

The largest new positions opened in Q4 2023 were PXD ($701.63M), HES ($428.88M), VSTS ($115.63M).

Of the 23 positions fully exited versus the prior quarter, the largest were ATVI ($1.90B), VMW ($915.39M), HZNP ($770.13M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • PXD PIONEER NAT RES CO · $701.63M
  • HES HESS CORP · $428.88M
  • VSTS VESTIS CORPORATION · $115.63M
  • UTHR UNITED THERAPEUTICS CORP DEL · $104.67M
  • CTLT CATALENT INC · $63.49M
  • COR CENCORA INC · $34.71M
  • IMGN IMMUNOGEN INC · $24.97M
  • CERE CEREVEL THERAPEUTICS HLDNG I · $24.05M

Fully Exited (vs previous quarter)

  • ATVI ACTIVISION BLIZZARD INC · prev qtr: $1.90B
  • VMW VMWARE INC · prev qtr: $915.39M
  • HZNP HORIZON THERAPEUTICS PUB L · prev qtr: $770.13M
  • SGEN SEAGEN INC · prev qtr: $481.69M
  • AON AON PLC · prev qtr: $215.82M · history
  • ELV ELEVANCE HEALTH INC FORMERLY · prev qtr: $166.04M
  • CI THE CIGNA GROUP · prev qtr: $104.70M
  • XYZ BLOCK INC · prev qtr: $103.41M

Insider Transactions (Form 4)

Latest Tom Steyer buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Farallon Capital Management is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q2 2026 it reported 86 US equity positions with a combined value of $21.54B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-51763 (status: Approved), registered 1996-04-01
  • Regulatory AUM (Form ADV): $52.08B as of 2026-09-23
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 50 private funds, of which 50 hedge funds
  • Website: faralloncapital.com

Portfolio Structure

  • 86 positions · $21.54B reported value (Q2 2026)
  • Top 10 holdings = 62.5% of reported value
  • Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 20.8%
  • Average position size: $250.46M

Sector Tilt

  • Health Care 51.2%
  • Information Technology 6.7%
  • Consumer Discretionary 4.0%
  • (classified holdings cover 70% of value)

Quarterly Activity

  • Q2 2026: 20 new, 29 added, 23 reduced, 103 exited
  • 14 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 21.1%
Technology 12.4%
Financials 10.9%
Other 37.1%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 12.34M $5.87B 26.97%
26.97%
Add
2 3.12M $701.63M 3.23%
3.23%
New
3 2.96M $685.12M 3.15%
3.15%
Add
4 26.63M $638.96M 2.94%
2.94%
Add
5 1.20M $638.61M 2.94%
2.94%
Add
6 1.20M $633.13M 2.91%
2.91%
Reduce
7 9.12M $626.84M 2.88%
2.88%
Reduce
8 1.93M $506.74M 2.33%
2.33%
Reduce
9 1.34M $503.36M 2.31%
2.31%
Reduce
10 3.94M $499.77M 2.30%
2.30%
Add
11 16.90M $474.87M 2.18%
2.18%
Add
12 9.48M $464.27M 2.13%
2.13%
Add
13 3.14M $442.31M 2.03%
2.03%
Reduce
14 2.98M $428.88M 1.97%
1.97%
New
15 4.25M $395.26M 1.82%
1.82%
Reduce
16 882.60K $388.80M 1.79%
1.79%
Reduce
17 6.57M $382.01M 1.76%
1.76%
Add
18 5.82M $336.47M 1.55%
1.55%
Add
19 533.00K $333.14M 1.53%
1.53%
Reduce
20 799.14K $310.61M 1.43%
1.43%
Reduce
21 4.13M $306.64M 1.41%
1.41%
Reduce
22 421.25K $297.61M 1.37%
1.37%
Reduce
23 1.49M $295.68M 1.36%
1.36%
Reduce
24 3.12M $272.78M 1.25%
1.25%
Add
25 38.19M $267.72M 1.23%
1.23%
Hold
26 619.47K $264.21M 1.22%
1.22%
Add
27 832.09K $259.53M 1.19%
1.19%
Reduce
28 3.82M $257.57M 1.18%
1.18%
Reduce
29 4.72M $255.23M 1.17%
1.17%
Reduce
30 1.70M $222.22M 1.02%
1.02%
Reduce
31 3.47M $217.67M 1.00%
1.00%
Add
32 798.11K $207.79M 0.95%
0.95%
Add
33 1.32M $201.71M 0.93%
0.93%
Add
34 6.74M $193.21M 0.89%
0.89%
Add
35 188.10M $182.17M 0.84%
0.84%
Hold
36 855.10K $173.95M 0.80%
0.80%
Add
37 522.00K $165.22M 0.76%
0.76%
Add
38 1.31M $153.74M 0.71%
0.71%
Add
39 5.73M $131.49M 0.60%
0.60%
Add
40 2.45M $119.17M 0.55%
0.55%
Add
41 2.02M $118.94M 0.55%
0.55%
Add
42 1.21M $116.69M 0.54%
0.54%
Reduce
43 5.47M $115.63M 0.53%
0.53%
New
44 4.11M $111.76M 0.51%
0.51%
Reduce
45 476.00K $104.67M 0.48%
0.48%
New
46 123.35M $93.88M 0.43%
0.43%
Add
47 4.17M $92.81M 0.43%
0.43%
Add
48 1.09M $90.82M 0.42%
0.42%
Add
49 7.34M $82.38M 0.38%
0.38%
Add
50 1.56M $78.67M 0.36%
0.36%
Add

FAQ

What did FARALLON CAPITAL MANAGEMENT, L.L.C. buy in 2023-Q4?

In its 2023-Q4 13F filing, FARALLON CAPITAL MANAGEMENT, L.L.C. reported 156 equity positions worth $21.75B in aggregate; its largest disclosed positions were SPY ($5.87B), PXD ($701.63M), IQV ($685.12M).

How large is FARALLON CAPITAL MANAGEMENT, L.L.C.'s portfolio?

FARALLON CAPITAL MANAGEMENT, L.L.C. reported $21.75B of long equity holdings across 156 positions as of 2023-Q4. Top-10 holdings account for 52.0% of reported value.

What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s investment style?

HoldingsHub classifies the portfolio as Large / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/farallon-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →